Pan-cancer analysis of <i>BRK1</i> as a potential immunotherapeutic target-Reference-Cited by-同舟云学术

Pan-cancer analysis of BRK1 as a potential immunotherapeutic target

Published:2023-03-29 Issue: Volume: Page:1-23
ISSN:0264-8725
Container-title:Biotechnology and Genetic Engineering Reviews
language:en
Short-container-title:Biotechnology and Genetic Engineering Reviews

Author:

Wang Xuefeng¹,Tang Yanru²,Liu Rui³,Li Wentao⁴,Liu Shiyue⁵,Zhou Xinhong¹

Affiliation:

1. Department of Hepatobiliary Surgery, Xiantao First People ‘s Hospital of Yangtze University, Xiantao, Hubei, China

2. Department of Respiratory, Xiantao First People ‘s Hospital of Yangtze University, Xiantao, Hubei, China

3. Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China

4. Department of Hepatobiliary Surgery, First Affiliated Hospital of Kunming Medical University, Kunming, China

5. Department of Pathology, First Affiliated Hospital of Kunming Medical University, Kunming, China

Funder

no financial support for the research, authorship, and/or publication of this article

Publisher

Informa UK Limited

Subject

Molecular Biology,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02648725.2023.2196179

Reference60 articles.

1. Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses

2. Tumor Microenvironment

3. Tumour necrosis factor and cancer

4. Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy

5. Landscape of Microsatellite Instability Across 39 Cancer Types

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized Therapies in Hepatocellular Carcinoma: Insights from a Disulfidptosis-Related Signature;2024-01-24